Efficient siRNA delivery with non-viral polymeric vehicles

Pharmaceutical Research

Volumn 26, Issue 3, 2009, Pages 657-666

  Kim, W J ^a   Kim, S W ^b  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

Cationic polymer; Gene therapy; Polymeric carrier; Small interfering RNA

Indexed keywords

APTAMER; ARGINYLGLYCYLASPARTIC ACID; DRUG CARRIER; MACROGOL; POLYMER; PROTAMINE; SMALL INTERFERING RNA;

DRUG SPECIFICITY; DRUG STABILITY; DRUG UPTAKE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENE SILENCING; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; VIRAL GENE DELIVERY SYSTEM;

CATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LIPOSOMES; MOLECULAR STRUCTURE; PEPTIDES; POLYMERS; RNA, SMALL INTERFERING;

EID: 60049097220     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9774-1     Document Type: Review

References (95)

1. D. Bumcrot M. Manoharan V. Koteliansky D. W. Sah 2006 RNAi therapeutics: a potential new class of pharmaceutical drugs Nat. Chem. Biol. 2 711 719
2. A. de Fougerolles H. P. Vornlocher J. Maraganore J. Lieberman 2007 Interfering with disease: a progress report on siRNA-based therapeutics Nat. Rev. Drug Discov. 6 443 453
3. R. K. Leung P. A. Whittaker 2005 RNA interference: from gene silencing to gene-specific therapeutics Pharmacol. Ther. 107 222 239
4. G. L. Sen H. M. Blau 2005 Argonaute 2/RISC resides in sites of mammalian decay known as cytoplasmic bodies Nat. Cell Biol. 7 633 636
5. M. A. Behlke 2006 Progress towards in vivo use of siRNAs Mol. Ther. 13 644 670
6. D. H. Kim J. J. Rossi 2007 Strategies for silencing human disease using RNA interference Nat. Rev. Genet. 8 173 184
7. D. R. Corey 2007 Chemical modification: the key to clinical application of RNA interference? J. Clin. Invest. 117 3615 3622
8. B. Urban-Klein S. Werth S. Abuharbeid F. Czubayko A. Aigner 2005 RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo Gene Ther. 12 461 466
9. P. L. Felgner T. R. Gadek M. Holm R. Roman H. W. Chan M. Wenz J. P. Northrop G. M. Ringold M. Danielsen 1987 Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure Proc. Natl. Acad. Sci. USA 84 7413 7417
10. E. Vives P. Brodin B. Lebleu 1997 A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus J. Biol. Chem. 272 16010 16017
11. A. L. Jackson J. Burchard D. Leake A. Reynolds J. Schelter J. Guo J. M. Johnson L. Lim J. Karpilow K. Nichols W. Marshall A. Khvorova P. S. Linsley 2006 Position-specific chemical modification of siRNAs reduces off-target transcript silencing RNA 12 1197 1205
12. D. S. Schwarz G. Hutvagner T. Du Z. Xu N. Aronin P. D. Zamore 2003 Asymmetry in the assembly of the RNAi enzyme complex Cell 115 199 208
13. A. Khvorova A. Reynolds S. D. Jayasena 2003 Functional siRNAs and miRNAs exhibit strand bias Cell 115 209 216
14. A. Reynolds D. Leake Q. Boese S. Scaringe W. S. Marshall A. Khvorova 2004 Rational siRNA design for RNA interference Nat. Biotechnol. 22 326 330
15. D. A. Braasch S. Jensen Y. Liu K. Kaur K. Arar M. A. White D. R. Corey 2003 RNA interference in mammalian cells by chemically modified RNA Biochemistry 42 7967 7975
16. Y. L. Chiu T. M. Rana 2003 siRNA function in RNAi: a chemical modification analysis RNA 9 1034 1048
17. M. Amarzguioui T. Holen E. Babaie H. Prydz 2003 Tolerance for mutations and chemical modifications in a siRNA Nucleic Acids Res. 31 589 595
18. M. Rusckowski T. Qu A. Roskey S. Agrawal 2000 Biodistribution and metabolism of a mixed backbone oligonucleotide (GEM 231) following single and multiple dose administration in mice Antisense Nucleic Acid Drug Dev. 10 333 345
19. H. Zhang J. Cook J. Nickel R. Yu K. Stecker K. Myers N. M. Dean 2000 Reduction of liver Fad expression by an antisense oligonucleotide protects mice from fulminant hepatitis Nat. Biotechnol. 18 862 867
20. A. M. Kawasaki M. D. Casper S. M. Freier E. A. Lesnik M. C. Zounes L. L. Cummins C. Gonzalez P. D. Cook 1993 Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease resistant antisense compounds with high affinity and specificity for RNA targets J. Med. Chem. 36 831 841
21. C. R. Allerson N. Sioufi R. Jarres T. P. Prakash N. Naik A. Berdeja L. Wanders R. H. Griffey E. E. Swayze B. Bhat 2005 Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA J. Med. Chem. 48 901 904
22. Y. L. Chiu A. Ali C. Y. Chu H. Cao T. M. Rana 2004 Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells Chem. Biol. 11 1165 1175
23. J. Soutschek A. Akinc B. Bramlage K. Charisse R. Constien M. Donoghue S. Elbashir A. Geick P. Hadwiger J. Harborth M. John V. Kesavan G. Lavine R. K. Pandey T. Racie K. G. Rajeev I. Rohl I. Toudjarska G. Wang S. Wuschko D. Bumcrot V. Koteliansky S. Limmer M. Manoharan H. P. Vornlocher 2004 Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 432 173 178
24. S. H. Kim J. H. Jeong S. H. Lee S. W. Kim T. G. Park 2008 Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer J. Control. Rel. 129 107 116
25. M. Lee S. W. Kim 2002 Polymeric gene carriers Pharm. News 9 407 415
26. M. Lee S. W. Kim 2005 Polyethylene glycol-conjugated copolymers for plasmid DNA delivery Pharm. Res. 22 1 10
27. E. Song P. Zhu S. K. Lee D. Chowdhury S. Kussman D. M. Dykxhoorn Y. Feng D. Palliser D. B. Weiner P. Shankar W. A. Marasco J. Lieberman 2005 Antibody mediated in vivo delivery of small interfering RNAs via cell surface receptors Nat. Biotechnol. 23 709 714
28. J. O. McNamara E. R. Andrechek Y. Wang K. D. Viles R. E. Rempel E. Gilboa B. A. Sullenger P. H. Giangrande 2006 Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras Nat. Biotechnol. 24 1005 1015
29. B. J. Hicke A. W. Stephens 2000 Escort aptamers; a delivery service for diagnosis and therapy J. Clin. Invest. 106 923 928
30. M. Blank T. Weinschenk M. Priemer H. Schluesener 2001 Systemic evolution of a DNA aptamer binding to rat brain tumor microvessels. Selective targeting of endothelial regulatory protein pigpen J. Biol. Chem. 276 16464 16468
31. D. A. Daniels H. Chen B. J. Hicke K. M. Swiderek L. Gold 2003 A tenascin-C aptamer identified by tumor cell SELEX: systemic evolution of ligands by exponential enrichment Proc. Natl. Acad. Sci. USA 100 15416 15421
32. K. N. Morris K. B. Jensen C. M. Julin M. Weil L. Gold 1998 High affinity ligands from in vitro selection: complex targets Proc. Natl. Acad. Sci. U. S. A. 95 2902 2907
33. T. C. Chu K. Y. Twu A. D. Ellington M. Levy 2006 Aptamer mediated siRNA delivery Nucleic Acids Res. 34 e73
34. S. Akhtar M. D. Hughes A. Khan M. Bibby M. Hussain Q. Nawaz J. Double P. Sayyed 2000 The delivery of antisense therapeutics Adv. Drug Deliv. Rev. 44 3 21
35. M. D. Hughes M. Hussain Q. Nawaz P. Sayyed S. Akhtar 2001 The cellular delivery of antisense oligonucleotides and ribozymes Drug Discov. Today 6 303 315
36. I. R. Gilmore S. P. Fox A. J. Hollins M. Sohail S. Akhtar 2004 The design and exogenous delivery of siRNA for post-transcriptional gene silencing J. Drug Target 12 315 340
37. S. Kawakami M. Hashida 2007 Targeted delivery systems of small interfering RNA by systemic administration Drug Metab. Pharmacokinet. 22 142 151
38. O. Boussif F. Lezoualc'h M. A. Zanta M. D. Mergny D. Scherman B. Demeneix J. P. Behr 1995 A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethyleneimine Proc. Natl. Acad. Sci. U. S. A. 92 7297 7301
39. A. Aigner 2006 Delivery systems for the direct application of siRNAs to induce RNA interference(RNAi) in vivo J. Biomed. Biotechnol. 4 71659
40. D. Fischer T. Bieber Y. Li H. P. Elsasser T. Kissel 1999 A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity Pharm. Res. 16 1273 1279
41. P. Marschall N. Malik Z. Larin 1999 Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine Gene Ther. 6 1634 1637
42. W. T. Godbey M. A. Barry P. Saggau K. K. Wu A. G. Mikos 2000 Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery J. Biomed. Mater. Res. 51 321 328
43. A. V. Harpe H. Petersen Y. Li T. Kissel 2000 Characterization of commercially available and synthesized polyethylenimines for gene delivery J. Control. Rel. 69 309 322
44. K. Kunath A. V. Harpe D. Fischer H. Petersen U. Bickel K. Voigt T. Kissel 2003 Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine J. Control. Rel. 89 113 125
45. M. L. Read S. Singh Z. Ahmed M. Stevenson S. S. Briggs D. Oupicky L. B. Barrett R. Spice M. Kendall M. Berry J. A. Preece A. Logan L. W. Seymour 2005 A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids Nucleic Acids Res. 33 e86
46. M. Thomas J. J. Lu Q. Ge C. Zhang J. Chen A. M. Klibanov 2005 Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung Proc. Natl. Acad. Sci. U. S. A. 102 5679 5684
47. A. C. Grayson A. M. Doody D. Putnam 2006 Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro Pharm. Res. 23 1868 1876
48. A. Zintchenko A. Philipp A. Dehshahri E. Wagner 2008 Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity Bioconjug. Chem. 19 1448 1455
49. C. H. Ahn S. Y. Chae Y. H. Bae S. W. Kim 2002 Biodegradable poly(ethylenimine) for plasmid DNA delivery J. Control. Rel. 80 273 282
50. S. Han R. I. Mahato S. W. Kim 2001 Water-soluble lipopolymer for gene delivery Bioconjugate Chem. 12 337 345
51. J. W. Yockman A. Maheshwari S. Han S. W. Kim 2003 Tumor regression by repeated intratumoral delivery of water soluble lipopolymers/p2CMVmIL-12 complexes J. Control. Rel. 87 177 186
52. M. Lee J. Rentz S. Han D. A. Bull S. W. Kim 2003 Water-soluble lipopolymer as an efficient carrier for gene delivery to myocardium Gene Ther. 10 585 593
53. M. Lee J. Rentz M. Bikram S. Han D. A. Bull S. W. Kim 2003 Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer Gene Ther. 10 1535 1542
54. W. J. Kim C. W. Chang M. Lee S. W. Kim 2007 Efficient siRNA delivery using water soluble lipopolymer for anti-angiogenic gene therapy J. Control. Rel. 118 357 363
55. J. H. Jeong L. V. Christensen J. W. Yockman Z. Zhong J. F. Engbersen W. J. Kim J. Feijen S. W. Kim 2007 Reducible poly(amido ethylenimine) directed to enhance RNA interference Biomaterials 28 1912 1917
56. M. Breunig C. Hozsa C. U. Lungwitz K. Watanabe I. Umeda H. Kato A. Goepferich 2008 Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo J. Control. Rel. 130 57 63
57. D. W. Bartlett M. E. Davis 2008 Impact of tumor-specific targeting and dosing schedule on tumor growth inhibition after intravenous administration of siRNA-containing nanoparticles Biotechnol. Bioeng. 99 975 985
58. S. Hu-Lieskovan J. D. Heidel D. W. Bartlett M. E. Davis T. J. Triche 2005 Sequence-specific knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in murine model of metastatic Ewing's sarcoma Cancer Res. 65 8984 8992
59. J. D. Heidel Z. Yu J. Y. Liu S. M. Rele Y. Liang R. K. Zeidan D. J. Kornbrust M. E. Davis 2007 Administration in non-human primates of escalating intravenous doses of targeted nanoparticles containing ribonucleotide reductase subunit M2 siRNA Proc. Natl. Acad. Sci. U. S. A. 104 5715 5721
60. U. N. Verma R. M. Surabhi A. Schmaltieg C. Becerra R. B. Gaynor 2003 Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells Clin. Cancer Res. 9 1291 1300
61. A. S. Arnold Y. L. Tang K. Qian L. Shen V. Valencia M. I. Phillips Y. C. Zhang 2007 Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia J. Hypertens. 25 197 205
62. T. S. Zimmermann A. C. Lee A. Akinc B. Bramlage D. Bumcrot M. N. Fedoruk J. Harborth J. A. Heyes L. B. Jeffs M. John A. D. Judge K. Lam K. McClintock L. V. Nechev L. R. Palmer T. Racie I. Röhl S. Seiffert S. Shanmugam V. Sood J. Soutschek I. Toudjarska A. J. Wheat E. Yaworski W. Zedalis V. Koteliansky M. Manohara H. P. Vornlocher I. MacLachlan 2006 RNAi-mediated gene silencing in non-human primates Nature 441 111 114
63. T. Suzuki S. Futaki M. Niwa S. Tanaka K. Ueda Y. Sugiura 2002 Possible existence of common internalization mechanisms among arginine-rich peptides J. Biol. Chem. 277 2437 2443
64. V. P. Torchilin R. Rammohan V. Weissig T. S. Levchenko 2001 Tat peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in presence of metabolic inhibitors Proc. Natl. Acad. Sci. U. S. A. 98 8786 8791
65. J. P. Richard K. Melikov E. Vives C. Ramos B. Verbeure M. J. Gait L. V. Chernomordik B. Lebleu 2003 Cell-penetrating peptides: a reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 585 590
66. J. A. Lecifert S. Harkins J. L. Whitton 2002 Full-length proteins attached to the HIV tat protein transduction domain are neither transduced between cells, nor exhibit enhanced immunogenicity Gene Ther. 9 1422 1428
67. D. Derossi A. H. Joliot G. Chassaing A. Prochiantz 1994 The third helix of the antennapedia homeodomain translocates through biological membranes J. Biol. Chem. 269 10444 10450
68. M. Pooga C. Kut M. Kihlmark M. Hällbrink S. Fernaeus R. Raid T. Land E. Hallberg T. Bartfai U. Langel 2001 Cellular translocation of proteins by transportan FASEB J. 15 1451 1453
69. S. Futaki T. Suzuki W. Ohashi T. Yagami S. Tanaka K. Ueda Y. Sugiura 2001 Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery J. Biol. Chem. 276 5836 5840
70. A. Muratovska M. R. Eccles 2004 Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells FEBS Lett. 558 63 68
71. T. J. Davidson S. Harel V. A. Arboleda G. F. Prunell M. L. Shelanski L. A. Greene C. M. Troy 2004 Highly efficient small interfering RNA delivery to primary mammalian neurons induces microRNA-like effects before mRNA degradation J. Neurosci. 24 10040 10046
72. J. J. Turner S. Jones M. M. Fabani G. Ivanova A. A. Arzumanov M. J. Gait 2007 RNA targeting 1with peptide conjugates of oligonucleotides, siRNA and PNA Blood Cells Mol. Dis. 38 1 7
73. S. W. Jones R. Christison K. Bundell C. J. Voyce S. M. Brockbank P. Newham M. A. Lindsay 2005 Characterization of cell-penetrating peptide-mediated peptide delivery Br. J. Pharmacol. 145 1093 1102
74. W. J. Kim L. V. Christensen S. Jo J. W. Yockman J. H. Jeong Y. H. Kim S. W. Kim 2006 Cholesteryl oligoarginine delivering vascular endothelial growth factor siRNA effectively inhibits tumor growth in colon adenocarcinoma Mol. Ther. 14 343 350
75. M. Hashida M. Nishikawa F. Yamashita Y. Takakura 2001 Cell-specific delivery of genes with glycosylated carriers Adv. Drug Deliv. Rev. 52 187 196
76. Y. H. Choi F. Liu J. S. Park S. W. Kim 1998 Lactose-poly(ethylene glycol)-grafted poly-l-lysine as hepatoma cell-targeted gene carrier Bioconjug. Chem. 9 708 718
77. T. Bettinger J. S. Remy P. Erbacher 1999 Size reduction of galactosylated PEI/DNA complexes improves lectin-mediated gene transfer into hepatocytes Bioconjug. Chem. 10 558 561
78. K. Sagara S. W. Kim 2002 A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes J. Control. Rel. 79 271 281
79. M. Oishi Y. Nagasaki K. Itaka N. Nishiyama K. Kataoka 2005 Lactosylated poly(ethylene glycol)-siRNA conjugate through acid-labile beta-thiopropionate linkage to construct pH-sensitive polyion complex micelles achieving enhanced gene silencing in hepatoma cells J. Am. Chem. Soc. 127 1624 1625
80. J. F. Ross P. K. Chaudhuri M. Ratnam 1994 Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications Cancer 73 2432 2443
81. S. Wang R. J. Lee G. Cauchon D. G. Gorenstein P. S. Low 1995 Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol Proc. Natl. Acad. Sci. U. S. A. 92 3318 3322
82. J. J. Turek C. P. Leamon P. S. Low 1993 Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells J. Cell Sci. 106 423 430
83. K. A. Mislick J. D. Baldeschwieler J. F. Kayyem T. J. Meade 1995 Transfection of folate-polylysine DNA complexes: evidence for lysosomal delivery Bioconjug. Chem. 6 512 515
84. S. H. Kim H. J. Mok J. M. Jeong S. W. Kim T. G. Park 2006 Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL Bioconjug. Chem. 17 241 244
85. S. H. Kim H. J. Jeong C. K. Cho S. W. Kim T. G. Park 2005 Target-specific gene silencing by siRNA plasmid DNA complexed with folate-modified poly(ethylenimine) J. Control. Rel. 104 223 232
86. P. C. Brooks R. A. Clark D. A. Cheresh 1994 Requirement of vascular integrin alpha 5 beta 3 for angiogenesis Science 264 569 571
87. D. A. Sipkins D. A. Cheresh M. R. Kazemi L. M. Nevin M. D. Bednarski K. C. Li 1998 Detection of tumor angiogenesis in vivo by alpha 5 beta3-targeted magnetic resonance imaging Nat. Med. 4 623 626
88. W. J. Kim J. M. Yockman M. Lee J. H. Jeong Y. H. Kim S. W. Kim 2005 Soluble Flt-1 gene delivery using PEI-g-PEG-RGD conjugate for anti-angiogenesis J. Control. Rel. 106 224 234
89. W. J. Kim J. M. Yockman J. H. Jeong L. V. Christensen M. Lee Y. H. Kim S. W. Kim 2006 Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice J. Control. Rel. 114 381 388
90. R. M. Schiffelers A. Ansari J. Xu Q. Zhou Q. Tang G. Storm G. Molema P. Y. Lu P. V. Scaria M. C. Woodle 2004 Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res. 32 e149
91. P. Aisen 2004 Transferrin receptor 1 Int. J. Biochem. Cell Biol. 36 2137 2143
92. K. A. Howard U. L. Rahbek X. Liu C. K. Damgaard S. Z. Glud M. O. Andersen M. B. Hovgaard A. Schmitz J. R. Nyengaard F. Besenbacher J. Kjems 2006 RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system Mol. Ther. 14 476 484
93. J. Y. Pille H. Li E. Blot J. R. Bertrand L. L. Pritchard P. Opolon A. Maksimenko H. Lu J. P. Vannier J. Soria C. Malvy C. Soria 2006 Intravenous delivery of anti-rhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer Human Gene Ther. 17 1019 1026
94. A. Khan M. Benboubetra P. Z. Sayyed K. W. Ng S. Fox G. Beck I. F. Benter S. Akhtar 2004 Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies J. Drug Target 12 393 404
95. H. Kang R. DeLong M. H. Fisher R. L. Juliano 2005 Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides Pharm. Res. 22 2099 2106